{"schema_version":"secwatch.filing_event.v1","accession":"0000916789-22-000072","form_type":"8-K","ticker":"HELE","cik":"0000916789","company_name":"HELEN OF TROY LTD","filed_at":"2022-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.032261+00:00","generated_at":"2026-06-23T05:16:37.160963+00:00","sec_items":["2.02","2.05","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Helen of Troy Q2 GAAP EPS $1.28, core adj EPS $2.27; announces Project Pegasus restructuring","bullets":["Consolidated net sales $521.4M (+9.7% YoY driven by acquisitions; organic down -1.5%).","GAAP diluted EPS $1.28 (down 39.3% YoY); core adj. diluted EPS $2.27 (down 14.3%).","FY2023 guidance lowered: net sales $2.00-2.05B, adj. EPS $9.00-9.40.","Board authorized Project Pegasus restructuring targeting $75-85M annualized pre-tax savings by FY2026, with $85-95M one-time charges.","Health & Wellness segment revenue up 27.6% (EPA benefit); Beauty segment down -15.4%."],"urls":{"canonical":"https://secwatch.observer/filing/0000916789-22-000072","json":"https://secwatch.observer/filing/0000916789-22-000072.json","markdown":"https://secwatch.observer/filing/0000916789-22-000072.md","text":"https://secwatch.observer/filing/0000916789-22-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/916789/000091678922000072/0000916789-22-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/916789/000091678922000072/hele-20220930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T05:16:37.160963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}